2 active not recruiting, 1 recruiting. .
Follow Elephas: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) Biopsy - Cancer, Immunotherapy | Recruiting | Elephas | 2000 | 2025-04-14 | 2026-06-29 | |
| Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) Core Needle Biopsy, Forceps Biopsy, Punch Biopsy - Immunotherapy, Cancer | Active not recruiting | Elephas | 416 | 2023-06-26 | 2026-06-29 | |
| Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (ELEPHAS-01) Core Needle, Forceps, or Punch Biopsy - NSCLC (Non-small Cell Lung Cancer), Metastatic NSCLC - Non-Small Cell Lung Cancer | Active not recruiting | Elephas | 200 | 2023-01-31 | 2026-06-29 |
Carcinoma, Non-Small-Cell Lung (3) · Colorectal Neoplasms (2) · Endometrial Neoplasms (2) · Head and Neck Neoplasms (2) · Kidney Neoplasms (2) · Liver Neoplasms (2) · Melanoma (2) · Neoplasms (2) · Skin Neoplasms (2) · Urinary Bladder Neoplasms (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Lung Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
Biopsy (1) · Biopsy, Large-Core Needle (1) · Biopsy, Needle (1) · Surgical Instruments (1)
United States (3)